Moderna announced today that they have started inoculating children vaccinated in a phased trial.

Called the KidCOVE study, Moderna will enroll  6,750 children in the US and Canada between the ages of 6 months and 11 years old.

Pfizer/BioNTech said they will start children in their trials and J&J also has plans to study the COVID vaccine in teenagers from 12-18.

 

About The Author

CEO/FOUNDER

Evan Hosie has worked as a Women's Lifestyle editor/writer (expert in the beauty and fashion vertical); created the Pop Culture section for Radaronline.com; never met a gadget she didn't want, and spends waaaaay too much time on Social Media.

Related Posts